logo
logo

NeuroNetworks Fund Leads $300,000 Seed Financing for MindNest Health, a Yale University Spinout

Apr 08, 2020•over 5 years ago

Amount Raised

$300,000

Round Type

seed

New York

Description

NeuroNetworks Fund (NNF), a 501(c)(3) venture fund investing in innovative treatments for autism, epilepsy and schizophrenia, today announced a $300,000 seed financing for MindNest Health, a digital health start-up developing tools and training for families of a child with autism or other behavioral conditions. The funds, provided by NNF and Connecticut Innovations, will be released in tranches on achievement of milestones. Connecticut Innovations is the strategic venture capital arm for the state of Connecticut. These funds will allow MindNest to advance its digital parent-training program to beta testing.

Company Information

Company

Neuro Networks Fund

Location

New York, New York, United States

About

The Fund, a nonprofit 501(c) (3) melds venture capital and charitable giving under one umbrella, providing a continuous circle of investment in promising research in neuro-disorders. The Fund helps to fill the gap between government funding, which has grown scarcer in recent years and private capital that has become more risk adverse regarding drug development in the neurodisease sector. Under this model, the Fund will begin a major philanthropic fund-raising campaign and use the charitable donations to invest in entrepreneurial companies developing new drugs and diagnostics. All investment returns then will be recycled to allow to the Fund to continue its charitable mission and become self-sustaining.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech